0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > COMP

COMP

Brief Information

Name:Sodium channel protein type VIII alpha subunit
Target Synonym:Sodium channel protein type 8 subunit alpha,Sodium channel protein type VIII subunit alpha,MED,SCN8A,Sodium Voltage-Gated Channel Alpha Subunit 8,Voltage-Gated Sodium Channel Subunit Alpha Nav1.6,Sodium Channel, Voltage Gated, Type VIII, Alpha Polypeptide
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
COP-H5220 Human Human COMP / TSP5 Protein, His Tag
COP-H5220-structure
COP-H5220-sds

Synonym Name

COMP,TSP5,EDM1,EPD1,MED,PSACH,THBS5

Background

Cartilage oligomeric matrix protein (COMP) is also known as Thrombospondin-5 (TSP5), EDM1, EPD1, MED, PSACH, THBS5, which belongs to the thrombospondin family. COMP / TSP5 contains 4 EGF-like domains, 1 TSP C-terminal (TSPC) domain, 8 TSP type-3 repeats. Abundantly expressed in the chondrocyte extracellular matrix, and is also found in bone, tendon, ligament and synovium and blood vessels. COMP may play a role in the structural integrity of cartilage via its interaction with other extracellular matrix proteins such as the collagens and fibronectin. COMP can mediate the interaction of chondrocytes with the cartilage extracellular matrix through interaction with cell surface integrin receptors. Thrombospondin-5 could play a role in the pathogenesis of osteoarthritis. COMP is a marker of cartilage turnover.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Pirmenol Hydrochloride CI-845 Approved Pfizer Pharmaceuticals Ltd (China), Sumitomo Dainippon Pimavar, Pimenol Japan Arrhythmias, Cardiac null 1994-01-01 Arrhythmias, Cardiac Details
Pilsicainide Hydrochloride DU-6552; SUN-1165 Approved Daiichi Sankyo Co Ltd Sunrythm Japan Tachycardia Daiichi Sankyo Co Ltd 1991-03-29 Tachycardia Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
PRAX-330 Phase 1 Clinical Epilepsy Details
PRAX-562 PRAX-562 Praxis Precision Medicines Details
XEN-901 NBI-921352; XEN-901 Phase 2 Clinical Xenon Pharma Brain Diseases; Epilepsy Details

This web search service is supported by Google Inc.

totop